v3.26.3
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule Components of the Company's Income Tax Expense
The components of the Company’s income tax expense for the years ended December 31, 2025 and 2024, were as follows:
 
     2025      2024  
Current taxes:
     
Foreign
   $ 8,883      $ 5,252  
  
 
 
    
 
 
 
Total income tax expense/(benefit)
   $ 8,883      $ 5,252  
  
 
 
    
 
 
 
Schedule of a Reconciliation of the Company's Effective Tax Rate to the U.S. Federal Statutory Income Tax Rate
A reconciliation of the Company’s effective tax rate to the U.S. federal statutory income tax rate for the years ended December 31, 2025 and 2024, is as follows:
 
     2025      2025     2024      2024  
Federal statutory rate
     1,912,292        21.00 %      1,997,362        21.00 % 
Foreign Tax Effect
     (2,665 )       0.00 %      (2,719 )       -0.03 % 
Permanent Differences
     1,934        0.00 %      3,811        0.04 % 
Valuation allowance
     (1,794,202 )       -19.70 %      (1,987,047 )       -20.89 % 
Effect of cross-border tax laws
     (7,628 )       -0.10       (7,482 )       -0.08  
Nontaxable or nondeductible items
     (99,885 )       -1.10 %      (9,177 )       -0.10 % 
Other
     (18,729 )       -0.20 %      —         0.00 % 
  
 
 
    
 
 
   
 
 
    
 
 
 
Effective tax rate
     (8,883 )       (0.1 )%      (5,252 )       (0.06 )% 
  
 
 
    
 
 
   
 
 
    
 
 
 
Schedule of Deferred Tax Assets And Liabilities
Deferred tax assets and liabilities as of December 31, 2025 and 2024, consisted of the following:
 
     2025     2024  
Deferred tax assets
    
Net operating losses
   $ 2,850,031     $ 890,289  
Lease liability
     205,630       215,272  
Capitalized research and development
     2,589,415       2,420,060  
Research and development credit
     348,597       157,265  
Stock-based compensation
     18,276       20,815  
Fixed Asset
     21,887       —   
  
 
 
   
 
 
 
Total deferred tax assets
     6,033,836     $ 3,703,701  
  
 
 
   
 
 
 
Deferred tax liabilities
    
ROU asset
     (192,565 )      (207,413 ) 
Fixed Asset
     —        (246,330 ) 
  
 
 
   
 
 
 
Total deferred tax liabilities
     (192,565 )      (453,743 ) 
  
 
 
   
 
 
 
Less: valuation allowance
     (5,841,271 )      (3,249,958 ) 
  
 
 
   
 
 
 
Total
   $ —      $ —   
  
 
 
   
 
 
 
Schedule of Operating Loss Carryforwards And Tax Credit
As of December 31, 2025, the Company had the following net operating loss (“NOL”) and tax credit carryforwards:
 
     Amount      Expiration  
U.S. federal NOL
   $ 7,184,853        Indefinite  
State (California) NOL
     19,205,159        2042-2045  
California research and development credit
     441,261        2026-2030  
U.S. federal research and development payroll tax credit
     692,518        2029-2030  
Schedule of a Reconciliation of the Beginning and Ending Amounts of Unrecognized Tax Benefits
A reconciliation of the beginning and ending amounts of unrecognized tax benefits for the years ended December 31, 2025 and 2024, is as follows:
 
     2025      2024  
Balance at beginning of year
     (35,130 )       —   
Increase/(Decrease) for prior years
        —   
Increase/(Decrease) for current year
     (42,740 )       (35,130 ) 
  
 
 
    
 
 
 
Balance at end of year
     (77,870 )       (35,130 )